Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation

Autor: Martijn R. Meijerink, Foke van Delft, Cornelis van Kuijk, Jantien A. Vogel, Jill Witvliet, Marcus C. de Jong, Babs M Zonderhuis, Hester J. Scheffer, Tanja D. de Gruijl, Anita G.M. Stam, Marian A. E. de van der Schueren, Petrousjka van den Tol, Geert Kazemier, Marc G. Besselink, Freek Daams, Laurien G. P. H. Vroomen, Marleen C. A. M. Melenhorst

Publikováno v: Scheffer, H J, Vroomen, L G P H, de Jong, M C, Melenhorst, M C A M, Zonderhuis, B M, Daams, F, Vogel, J A, Besselink, M G H, van Kuijk, C, Witvliet, J, de van der Schueren, M A E, de Gruijl, T D, Stam, A G M, van den Tol, P M P, van Delft, F, Kazemier, G & Meijerink, M R 2016, ' Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation : Results of the Phase I/II PANFIRE Study ', Radiology, pp. 152835 . https://doi.org/10.1148/radiol.2016152835
Radiology. Radiological Society of North America Inc.
Radiology, 282(2), 585-597. Radiological Society of North America Inc.

Purpose To (a) investigate the safety of percutaneous irreversible electroporation (IRE) for locally advanced pancreatic cancer and (b) evaluate the quality of life (QOL), pain perception, and efficacy in terms of time to local progression, event-fre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b779a452ae5258aa8bcbfc356e3d28f
https://doi.org/10.1148/radiol.2016152835